| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |